Unspecified type of carcinoma in situ of left breast refers to a localized breast cancer that has not invaded surrounding tissues. This condition is clinically significant as it may progress to invasive cancer if not monitored and treated appropriately. The ICD-10 Code D05.92 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code D05.92 represents an unspecified type of carcinoma in situ of the left breast, indicating a non-invasive breast cancer that is confined to the ducts or lobules. This code should be used in clinical documentation and billing when a definitive diagnosis of carcinoma in situ is made, but the specific type is not specified. Accurate coding is essential for treatment planning and reimbursement.
Unspecified type of carcinoma in situ of the left breast is characterized by abnormal cell growth within the breast tissue that has not spread beyond its original site. This condition requires medical attention to prevent progression to invasive cancer. Risk factors include genetic predisposition, hormonal influences, and lifestyle factors.
ICD-10 Code D05.92 is utilized in SOAP notes to document the diagnosis of unspecified type of carcinoma in situ of the left breast. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D05.92 connects subjective patient reports and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of unspecified type of carcinoma in situ of the left breast may require hospitalization for surgical intervention or monitoring. Treatment approaches focus on preventing progression to invasive cancer.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.92 is crucial for billing purposes in hospital, ER, or oncology settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 19120 | Excision, breast, tumor, open, excisional biopsy. |
| 77067 | Mammography, bilateral, diagnostic. |
| 19281 | Breast biopsy, percutaneous, needle. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code D05.92 for Unspecified type of carcinoma in situ of left breast
What does carcinoma in situ mean?
Carcinoma in situ refers to a group of abnormal cells that are confined to their original location and have not invaded surrounding tissues. It is considered a non-invasive form of cancer.
How is carcinoma in situ diagnosed?
Carcinoma in situ is typically diagnosed through imaging studies such as mammograms and confirmed with a biopsy, where tissue samples are examined for abnormal cell growth.
What are the treatment options for carcinoma in situ?
Treatment options may include surgical excision, radiation therapy, and close monitoring. The choice of treatment depends on the specific characteristics of the carcinoma in situ.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a type of cancer, but it is non-invasive. It requires treatment to prevent progression to invasive cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes